The importance of the SMN genes in the genetics of sporadic ALS

References

• Moulard B, Salachas F, Chassande B, Briolotti V, Meininger V, Malafosse A, et al. Association between centromeric deletions of the SMN gene and sporadic adult onset lower motor neuron disease. Ann Neurol. 1998; 43: 640–4
   PubMed Web of Science ®Google Scholar
• Echaniz-Laguna A, Guiraud-Chaumeil C, Tranchant C, Reeber A, Melki J, Warter JM. Homozygous exon 7 deletion of the SMN centromeric gene (SMN2): a potential susceptibility factor for adult onset lower motor neuron disease. J Neurol. 2002; 249: 290–3
   PubMed Web of Science ®Google Scholar
• Corcia P, Khoris J, Couratier P, Mayeux-Portas V, Bieth E, De Toffol B, et al. SMN1 gene study in three families in which ALS and spinal muscular atrophy co-exist. Neurology 2002; 59: 1464–6
   PubMed Web of Science ®Google Scholar
• Lefebvre S, Bürglen L, Reboullet S, Clermont O, Burlet P, Viollet L, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995; 80: 155–65
   PubMed Web of Science ®Google Scholar
• Lorson CL, Androphy EJ. An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. Hum Molec Genet. 2000; 9: 259–65
   PubMed Web of Science ®Google Scholar
• Eggert C, Chari A, Laggerbauer B, Fischer U. Spinal muscular atrophy: the RNP connection. Trends in Molecular Medicine 2006; 12: 113–21
   PubMed Web of Science ®Google Scholar
• Lorson XL, Strasswimmer J, Yao JM, Baleja JD, Hahnen E, Wirth B, et al. SMN oligomerization defect correlates with spinal muscular atrophy severity. Nat Genet. 1998; 19: 63–6
   PubMed Web of Science ®Google Scholar
• Munsat TL, Davies KE. International SMA consortium meeting. Neuromusc Disord 1992; 2: 423–8
   PubMed Web of Science ®Google Scholar
• Gavrilov DK, Shi X, Das K, Gilliam TC, Wang CH. Differential SMN2 expression associated with SMA severity. Nat Genet. 1998; 20: 230–1
   PubMed Web of Science ®Google Scholar
• Harada Y, Sutomo R, Sadewa AH, Akutsu T, Takeshima Y, Wada H, et al. Correlation between SMN2 copy number and clinical phenotype of spinal muscular atrophy: three SMN2 copies fail to rescue some patients from disease severity. J Neurol. 2002; 249: 1211–9
   PubMed Web of Science ®Google Scholar
• Jackson M, Morrison KE, Al-Chalabi A, Bakker M, Leigh PN. Analysis of chromosome 5q13 genes in amyotrophic lateral sclerosis: homozygous NAIP deletion in a sporadic case. Ann Neurol. 1996; 39: 796–800
   PubMed Web of Science ®Google Scholar
• Orrell RW, Habgood JJ, de Belleroche JS, Lane RJ. The relationship of spinal muscular atrophy to motor neuron disease: investigation of SMN and NAIP gene deletions in sporadic and familial ALS. J Neurol Sci. 1997; 145: 55–61
   PubMed Web of Science ®Google Scholar
• Parboosingh JS, Meininger V, McKenna-Yasek D, Brown RH, Jr, Rouleau GA. Deletions causing spinal muscular atrophy do not predispose to amyotrophic lateral sclerosis. Arch Neurol. 1999; 56: 710–2
   PubMedGoogle Scholar
• Gamez J, Barceló MJ, Muñoz X, Carmona F, Cuscó I, Baiget M, et al. Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients. Neurology 2002; 59: 1456–60
   PubMed Web of Science ®Google Scholar
• Veldink JH, van den Berg LH, Cobben JM, Stulp RP, de Jong JM, Vogels OJ, et al. Homozygous deletion of the survival motor neuron 2 gene is a prognostic factor in sporadic ALS. Neurology 2001; 56: 749–52
   PubMed Web of Science ®Google Scholar
• Corcia P, Mayeux-Portas V, Khoris J, de Toffol B, Autret A, Müh JP, et al. Abnormal SMN1 gene copy number is a susceptibility factor for amyotrophic lateral sclerosis. Ann Neurol. 2002; 51: 243–6
   PubMed Web of Science ®Google Scholar
• Veldink JH, Kalmijn S, van der Hout AH, Lemmink HH, Groeneveld GJ, Lummen C, et al. SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS. Neurology 2005; 65: 820–5
   PubMed Web of Science ®Google Scholar
• Corcia P, Camu W, Halimi JM, Vourc'h P, Antar C, Vedrine S, et al. SMN1 gene, but not SMN2, is a risk factor for sporadic ALS. Neurology 2006; 67: 1147–50
   PubMed Web of Science ®Google Scholar
• Siddique T, Pericak-Vance MA, Caliendo J, Hong ST, Hung WY, Kaplan J, et al. Lack of association between apolipoprotein E genotype and sporadic amyotrophic lateral sclerosis. Neurogenetics 1998; 3: 213–6
   Web of Science ®Google Scholar
• Burnett BG, Sumner CJ. Targeting splicing in spinal muscular atrophy. Ann Neurol. 2008; 63: 3–5
   PubMed Web of Science ®Google Scholar
• Sugai F, Yamamoto Y, Miyaguchi K, Zhou Z, Sumi H, Hamasaki T, et al. Benefit of valproic acid in suppressing disease progression of ALS model mice. European Journal of Neuroscience 2004; 20: 3179–83
   PubMed Web of Science ®Google Scholar
• Piepers S, de Jong S, Veldink J, Groeneveld GJ, Sodaar P, Jansen M, et al. A randomized placebo-controlled sequential trail of valproid acid in ALS. Amyotroph Lateral Scler 2007; 8(Suppl 1)145
   Google Scholar
• Riessland M, Brichta L, Hahnen E, Wirth B. The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells. Hum Genet. 2006; 120: 101–10
   PubMed Web of Science ®Google Scholar
• Echaniz-Laguna A, Bousiges O, Loeffler JP, Boutillier AL. Histone deacetylase inhibitors: therapeutic agents and research tools for deciphering motor neuron diseases. Curr Med Chem. 2008; 15: 1263–73
   PubMed Web of Science ®Google Scholar
• Grzeschik SM, Ganta M, Prior TW, Heavlin WD, Wang CH. Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells. Ann Neurol. 2005; 58: 194–202
   PubMed Web of Science ®Google Scholar
• Angelozzi C, Borgo F, Tiziano FD, Martella A, Neri G, Brahe C. Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells. J Med Genet. 2008; 45: 29–31
   PubMed Web of Science ®Google Scholar
• Yuo CY, Lin HH, Chang YS, Yang WK, Chang JG. 5-(N-ethyl-N-isopropyl)-amiloride enhances SMN2 exon 7 inclusion and protein expression in spinal muscular atrophy cells. Ann Neurol. 2008; 63: 26–34
   PubMed Web of Science ®Google Scholar
• Wolstencroft EC, Mattis V, Bajer AA, Young PJ, Lorson CL. A non-sequence specific requirement for SM protein activity: the role of aminoglycosides in inducing elevated SMN protein levels. Hum Molec Genet. 2005; 14: 1199–210
   PubMed Web of Science ®Google Scholar
• Lunn MR, Root DE, Martino AM, Flaherty SP, Kelley BP, Coovert DD, et al. Indoprofen up-regulates the survival motor neuron protein through a cyclo-oxygenase-independent mechanism. Chem Biol. 2004; 11: 1489–93
   PubMed Web of Science ®Google Scholar
• Corcia P, Praline J, Vourc'h P, Andres C. Genetics of motor neuron disorders. Rev Neurol (Paris) 2008; 164: 115–30
   PubMed Web of Science ®Google Scholar
• Paubel A, Violette J, Amy M, Praline J, Meininger V, Camu W, et al. Mutations of the angiogenin gene in French patients with sporadic amyotrophic lateral sclerosis. Arch Neurol. 2008; 65: 1333–6
   PubMedGoogle Scholar
• Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, van de Velde C, et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet. 2008; 40: 572–4
   PubMed Web of Science ®Google Scholar
• Sleegers K, Brouwers N, Gijselinck I, Theuns J, Goossens D, Wauters J, et al. APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy. Brain. 2006; 129: 2977–83
   PubMed Web of Science ®Google Scholar
• Ibáñez P, Bonnet AM, Débarges B, Lohmann E, Tison F, Pollak P, et al. Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet. 2004; 364: 1169–71
   PubMed Web of Science ®Google Scholar
• Chance PF, Fischbeck KH. Molecular genetics of Charcot-Marie-Tooth disease and related neuropathies. Hum Mol Genet. 1994; 3: S1503–7
   PubMed Web of Science ®Google Scholar
• Simon Cronin S, Blauw HM, Veldink JH, van Es M, Ophoff R, Bradley D, et al. Analysis of genome-wide copy number variation in Irish and Dutch ALS populations. Hum Molec Genetics 2008; 21: 3392–8
   Web of Science ®Google Scholar
• Blauw H, Veldink J, van Es M, van Vught P, Saris C, van der Zwaag B, et al. Copy-number variation in sporadic amyotrophic lateral sclerosis: a genome-wide screen. Lancet Neurol. 2008; 7: 319–26
   PubMed Web of Science ®Google Scholar
• Roy N, Mahadevan MS, McLean M, Shutler G, Yaraghi Z, Faharani R, et al. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 1995; 80: 167–78
   PubMed Web of Science ®Google Scholar
• Kunst CB, Messer L, Gordon J, Haines J, Patterson D. Genetic mapping of a mouse modifier gene that can prevent ALS onset. Genomics 2000; 70: 181–9
   PubMed Web of Science ®Google Scholar